Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | ACR | P10323 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.39 |
| ▸ | RELA | Q04206 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14907487 | 0.94 | THRB (0.45) | THRBMAPTSMN1; SMN2PRSS1ACR | |
| SCHEMBL12162145 | 0.92 | MAPT (0.39) | THRBMAPTSMN1; SMN2PRSS1ACR | |
| SCHEMBL14907552 | 0.87 | THRB (0.47) | THRBSMN1; SMN2LMNACYP1A2CYP3A4 | |
| SCHEMBL14907432 | 0.87 | CYP2C9 (0.48) | THRBMAPTSMN1; SMN2PRSS1ACR | |
| SCHEMBL11917946 | 0.87 | CYP2C9 (0.48) | THRBMAPTSMN1; SMN2PRSS1ACR | |
| SCHEMBL14907456 | 0.85 | PTPN2 (0.42) | THRBNPC1CYP2C9TSHRHPGD | |
| SCHEMBL16746203 | 0.85 | CYP2C9 (0.48) | THRBMAPTSMN1; SMN2PRSS1ACR | |
| SCHEMBL16133502 | 0.85 | PTPN2 (0.42) | THRBNPC1CYP2C9TSHRHPGD | |
| SCHEMBL13252556 | 0.84 | PRSS1 (0.40) | THRBMAPTSMN1; SMN2PRSS1ACR | |
| SCHEMBL16379446 | 0.84 | THRB (0.61) | THRBMAPTSMN1; SMN2PRSS1ACR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100201920-A1 | Calamitic Mesogenic Compounds | MERCK PATENT GESELLSCHAFT (DE) | 2010-08-12 | — | — | US | disclosed |
| WO-2009030332-A1 | CALAMITIC MESOGENIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2009-03-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100201920-A1 | Calamitic Mesogenic Compounds | CALD1, CALR, CALU | THRB 4750/4885MAPT 473/4885SMN1; SMN2 3080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.